TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

NCT06251544 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Tumor, Breast
Breast Tumor
Malignant Neoplasm of Breast
Mammary Cancer
Mammary Neoplasm
Mammary Neoplasms, Human
Neoplasm, Breast

Interventions

GENETIC: HTR2 T Cells
GENETIC: HTR2 T Cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]